0.355

0.56% -0.002

After Hours: .36 0.005 +1.41%

Cosmos Health Inc (COSM)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cosmos Health Inc stock is traded at $0.355, with a volume of 380.98K. It is down -0.56% in the last 24 hours and up +15.71% over the past month. Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

Previous Close:

$0.357

Open:

$0.365

24h Volume:

380.98K

Relative Volume:

0.46

Market Cap:

$18.58M

Revenue:

$65.27M

Net Income/Loss:

$-19.15M

P/E Ratio:

-0.5718

EPS:

-0.6208

Net Cash Flow:

$-12.43M

1W Performance:

-4.16%

1M Performance:

+15.71%

6M Performance:

-50.93%

1Y Performance:

-22.42%

1-Day Range:

$0.3516

$0.3655

1-Week Range:

$0.3501

$0.40

52-Week Range:

$0.2805

$1.32

Cosmos Health Inc Stock (COSM) Company Profile

Name

Cosmos Health Inc

Sector

Healthcare (1106)

Industry

Medical Distribution (12)

Phone

312-536-3102

Address

5 AGIOU GEORGIOU, PILEA, THESSALONIKI

Employee

163

Twitter

Next Earnings Date

2026-05-21

Latest SEC Filings

COSM's Discussions on Twitter

Compare COSM vs MCK, COR, CAH, HSIC, AHG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COSM Cosmos Health Inc	0.355	18.68M	65.27M	-19.15M	-12.43M	-0.6208
MCK Mckesson Corp	801.01	98.95B	397.96B	4.55B	9.64B	34.77
COR Cencora Inc	305.90	59.07B	325.78B	1.64B	3.61B	8.3139
CAH Cardinal Health Inc	197.00	46.15B	250.74B	1.55B	4.39B	6.5398
HSIC Henry Schein Inc	74.37	8.26B	13.18B	419.00M	521.00M	3.2704
AHG Akso Health Group Adr	2.20	1.83B	14.85M	-136.07M	7.25M	-0.4726

Cosmos Health Inc Stock (COSM) Latest News

May 03, 2026

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months - ACCESS Newswire

Apr 30, 2026

A turmeric supplement is central to Cosmos Health's $2.5M U.S. sales bet - Stock Titan

Apr 30, 2026

Apr 25, 2026

Cosmos Health Continues US Expansion with Q2 Launch of Cur18a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health - ACCESS Newswire

Apr 25, 2026

Apr 24, 2026

Cosmos Health (COSM) holder reports 4.14M shares, 8.15% stake in amendment - Stock Titan

Apr 24, 2026

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Produ - Palestineherald.com

Apr 24, 2026

73.5M Cosmos Health shares registered for resale (NASDAQ: COSM) - Stock Titan

Apr 24, 2026

Apr 23, 2026

Cosmos Health (COSM) Year-Ahead Outlook | Q4 2025: Below ExpectationsAcquisition - Xã Vĩnh Công

Apr 23, 2026

Apr 22, 2026

Is Cosmos Health (COSM) stock still a good play today | Q4 2025: Profit DisappointsReal-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Cosmos Health (COSM) Stock: Consolidation Phase Insight (Smart Money Flows) 2026-04-22Quantitative Analysis - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 21, 2026

Cosmos Health Introduces the "18 Series" in the United StatesA Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products - Finviz

Apr 21, 2026